METHODS	An independent reading center measured the area of RNP on fluorescein angiograms ( FAs ) in 2 phase III trials investigating the effect of ranibizumab ( RBZ ; Lucentis ; Genentech , Inc , South San Francisco , CA ) in patients with CRVO or BRVO .\